Navigation Links
Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution
Date:7/24/2009

ANAHEIM, Calif., July 24 /PRNewswire/ -- Elekta CMS Software has received FDA 510(k) clearance for the VMAT enhancement to Monaco((R)), an advanced IMRT treatment planning solution that combines new levels of scientific insight with precise dose control.

Monaco with VMAT can optimize single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans. Reducing planning time and increasing clinical throughput, arc plans can be delivered with a single button push at the linear accelerator console, gantry directions automatically sorted and control points seamlessly integrated into a single deliverable arc sequence.

Monaco has been available for use clinically for the past two years for step-and-shoot IMRT planning. The product was developed in cooperation with Eberhard Karls Universitat Tuebingen in Germany.

A new paradigm in VMAT planning, Monaco incorporates biologically based objectives, constrained optimization, sensitivity analysis and unique smart sequencing. In addition, Monaco is the only planning platform that offers the accurate XVMC Monte Carlo dose engine for a continuous arc calculation as a single beam. The result gives clinicians the power to provide higher standard of patient care.

"We are extremely proud and very pleased to receive clearance to add this VMAT technique to Monaco in the U.S. market," said Rob Cessac, Product Manager for Elekta CMS Software. "Our continued support and development of leading approaches to cancer treatment promises to create a positive future for clinicians and patients."

For the latest Monaco with VMAT news, visit www.elekta.com/cms.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, visit elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting
2. Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
3. The Ottawa Hospital and Elekta Forge Long-Term Strategic Partnership Agreement
4. ProCure Treatment Centers to Equip Chicago Facility With Software Solutions From Elekta
5. Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body
6. Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions
7. Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness
8. Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
9. Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies
10. Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases
11. CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
Breaking Medicine Technology: